NOX4 and pancreatic neoplasm: These results may be of clinical relevance since NOX4 is increased in human pancreatic tumors, and specific inhibition of NOX4 with small molecule inhibitors act synergistically with chemotherapeutic agents in mouse models of this type of cancer [109].